Clinical Trials
61
Active:57
Completed:2
Trial Phases
3 Phases
Phase 1:54
Phase 2:2
Phase 4:2
Drug Approvals
32
NMPA:19
EMA:12
FDA:1
Drug Approvals
Recombinant Zoster Vaccine(CHO Cell)
- Product Name
- 欣安立适
- Approval Number
- 国药准字SJ20190026
- Approval Date
- Mar 20, 2024
NMPA
Human Papillomavirus (Types 16,18) Vaccine, Adsorbed
- Product Name
- 希瑞适
- Approval Number
- 国药准字SJ20160025
- Approval Date
- Aug 10, 2021
NMPA
Human Papillomavirus (Types 16,18) Vaccine, Adsorbed
- Product Name
- 希瑞适
- Approval Number
- 国药准字SJ20160026
- Approval Date
- Aug 10, 2021
NMPA
Human Papillomavirus (Types 16,18) Vaccine, Adsorbed
- Product Name
- 希瑞适
- Approval Number
- 国药准字SJ20160027
- Approval Date
- Aug 10, 2021
NMPA
Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae)
- Product Name
- 安在时
- Approval Number
- 国药准字SJ20150022
- Approval Date
- Jul 12, 2020
NMPA
Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae)
- Product Name
- 安在时
- Approval Number
- 国药准字SJ20150020
- Approval Date
- Jul 12, 2020
NMPA
Recombinant Zoster Vaccine(CHO Cell)
- Product Name
- 欣安立适
- Approval Number
- S20190026
- Approval Date
- May 21, 2019
NMPA
Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)
- Product Name
- 安在时
- Approval Number
- 国药准字J20170019
- Approval Date
- Mar 15, 2017
NMPA
Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)
- Product Name
- 安在时
- Approval Number
- J20170019
- Approval Date
- Mar 15, 2017
NMPA
Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)
- Product Name
- 安在时
- Approval Number
- 国药准字J20170020
- Approval Date
- Mar 15, 2017
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (59 trials with phase data)• Click on a phase to view related trials
Phase 1
54 (91.5%)Phase 2
2 (3.4%)Phase 4
2 (3.4%)phase_1_2
1 (1.7%)No trials found
News
No news found